Application

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 10/31/2024. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97298701

Filing Date: 03/07/2022

To the Commissioner for Trademarks:

MARK: (Stylized and/or Design, see mark) The color(s) green is/are claimed as a feature of the mark. The mark consists of a stylized design of the head of a snake below a plus symbol design all within a circle design.
The applicant, Protherics Medicines Development Limited, a private limited company legally organized under the laws of United Kingdom, having an address of
      C/O Collyer Bristow LLP
      140 Brompton Road
      Knightsbridge, London SW31HY
      United Kingdom
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 009:  Downloadable software in the nature of a mobile application for handheld computers, mobile computer devices, mobile phones, media players, that provides access to information, advice and calculation tools in the fields of healthcare, medicine, medical treatment and patient care; computer software for controlling and managing patient medical information; computer programs for controlling and managing patient medical information; computer programs for use in the field of healthcare for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, and clinical records; computer software for use by healthcare providers to analyze the outcomes of medical procedures and information relating to patient care; computer software for use in database management; computer database management software for clinical use, for clinical governance, clinical audit, collecting and analyzing information relating to patient demographics, procedures and outcomes; downloadable electronic publications in the nature of questionnaires on the subject of healthcare, medicine, medical treatment and patient care; downloadable electronic publications in the nature of patient reported outcome questionnaires on the subject of healthcare, medicine, medical treatment and patient care for use with a telecommunications device; computer software for enabling the user to utilise the camera facility on a mobile phone, handheld computer or other mobile device or computer to track symptoms; electronic computer databases featuring information about medical education in the fields of healthcare, medicine, medical treatment and patient care recorded on computer media

In International Class 009, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2016, and first used in commerce at least as early as 00/00/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) screenshots showing the mark as used in connection within a downloadable app.

Original PDF file:
SPE0-1732271929-202203041 85752520730_._Screenshots.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Webpage URL: None Provided
Webpage Date of Access: None Provided

International Class 041:  Education, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals, medical research, medical science, medicine and related treatments; providing online databases featuring education information about medical education in the fields of healthcare, medicine, medical treatment and patient care; educational services, namely, development of multi-media educational content for use with mobile devices and computers, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information in relation to the treatment of envenomation by snakes; training in the use and operation of pharmaceutical products, pharmaceutical preparations and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of healthcare, the use of pharmaceutical, medical research, medicine and related treatments; educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals, medical research, medicine, and related treatments; educational services , namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the fields of health; educational services, namely, providing non-downloadable webinars in the field of healthcare, the use of pharmaceuticals, medical research, medicine, and related treatments; education services, namely, conducting online and telephonic instruction and courses in the fields of healthcare, the use of pharmaceuticals, medical research, medicine, and related treatments; providing educational information and advice relating to education, training and education and training development provided online all relating to the treatment of envenomation by snakes; providing educational electronic online databases featuring information about medical education for medical purposes in the field of treatment of envenomation by snakes

In International Class 041, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2016, and first used in commerce at least as early as 00/00/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Marketing material showing the mark in connection with the services and screenshots showing the mark as used in connection within a downloadable app. Some of the services are also rendered through the application.

Original PDF file:
SPE0-1732271929-202203041 85752520730_._crofabcom20 22-03-04t23-46-52.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3
Original PDF file:
SPE0-1732271929-202203041 85752520730_._BTGP037-Pat ient-Transfer-Card-D8.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2
Original PDF file:
SPE0-1-1732271929-2022030 4185752520730_._Screensho ts.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Webpage URL: http://crofab.com/crofab-resources/snakebite911
Webpage Date of Access: 03/04/2022
Webpage URL: http://crofab.com/getmedia/2a948e24-7020-454a-8c2e-4c1ffd706e19/BTGP037-Patient-Transfer-Card-D8
Webpage Date of Access: 03/04/2022

International Class 044:  Medical services; provision of medical information; provision of an on-line computer database featuring medical information; providing medical information via the Internet and by telecommunication means; healthcare services; providing medical information; medical services relating to the treatment of envenomation by snakes; providing a website featuring medical information in the fields of medicine, medical treatment, patient care, prescription drugs, pharmaceutical ordering, prescribing information and instructions, and dispensing practices of drugs, medical treatment and aftercare; medical services, namely, diagnosis, assessment, treatment and aftercare in the field of envenomation by snakes; medical services in the nature of analysis for the diagnosis and treatment of persons; pharmacy advice, namely, medical advice on pharmaceuticals; medical services for diagnosis in the fields of treatment of envenomation by snakes; medical health assessment services in the field of treatment of envenomation by snakes; medical treatment services in the field of treatment of envenomation by snakes; medical after care services in the field of treatment of envenomation by snakes; medical advisory services relating to health and healthcare; medical advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; medical services for the purpose of patient diagnosis and treatment, namely, conducting health assessment surveys, health risk assessment surveys, treatment outcome surveys and health advice and health information services; health care consultancy services; consultancy services relating to medical treatment; information services relating to health care and medical treatment; providing health and medical information via telephonic hotline services, namely, providing medical records information to medical, medical counselling and nursing personnel to assist them with patient coverage, reimbursement, pharmaceutical ordering, and site-of-care medical support questions; provision of medical records by telephonic hotline services; healthcare consultancy services, namely, providing healthcare consulting via a telephonic hotline for medical, counselling and nursing personnel; healthcare consultancy services, namely, providing patient and patient medical record information by telephonic hotline services; providing health and medical information by telephonic hotline services; healthcare consultancy services; consultancy services relating to medical treatment; information services relating to healthcare and medical treatment; advisory services relating to medical treatment services; Medical services relating to treatment of snakebite envenomation; providing medical advisory, consultancy and information services relating to the aforesaid services; providing electronic online databases for medical purposes in the field of treatment of envenomation by snakes

In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 00/00/2016, and first used in commerce at least as early as 00/00/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Marketing material showing the mark in connection with the services and screenshots showing the mark as used in connection within a downloadable app. Some of the services are also rendered through the application.

Original PDF file:
SPE0-1-1732271929-2022030 4185752520730_._crofabcom 2022-03-04t23-46-52.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3
Original PDF file:
SPE0-1-1732271929-2022030 4185752520730_._BTGP037-P atient-Transfer-Card-D8.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2
Original PDF file:
SPE0-2-1732271929-2022030 4185752520730_._Screensho ts.pdf
Converted PDF file(s) (4 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Webpage URL: http://crofab.com/crofab-resources/snakebite911
Webpage Date of Access: 03/04/2022
Webpage URL: http://crofab.com/getmedia/2a948e24-7020-454a-8c2e-4c1ffd706e19/BTGP037-Patient-Transfer-Card-D8
Webpage Date of Access: 03/04/2022




The owner's/holder's proposed attorney information: Jonathan A. Hyman. Other appointed attorneys are John B. Sganga, Jr., Edward A. Schlatter, Gerard von Hoffmann, Joseph R. Re, Catherine J. Holland, Jeffrey L. Van Hoosear, Daniel E. Altman, Lynda J. Zadra-Symes, William H. Shreve, Stephen C. Jensen, Steven J. Nataupsky, Paul A. Stewart, Joseph F. Jennings, Craig S. Summers, Ronald J. Schoenbaum, John R. King, Adeel S. Akhtar, David N. Weiss, Douglas G. Muehlhauser, Lori Lee Yamato, Michael K. Friedland, Stacey R. Halpern, Jon W. Gurka, Joseph M. Reisman, Michael L. Fuller, Paul N. Conover, Robert J. Roby, Sabing H. Lee, Karoline A. Delaney, William R. Zimmerman, Eric S. Furman, Susan M. Natland, Rabinder N. Narula, Bruce S. Itchkawitz, John M. Grover, Irfan A. Lateef, Amy Christensen Chun, Mark J. Gallagher, Brian C. Horne, Payson LeMeilleur, Sheila N. Swaroop, Benjamin A. Katzenellenbogen, Andrew N. Merickel, Linda H. Liu, James F. Herkenhoff, Andrew M. Douglas, Salima A. Merani, Jonathan A. Hyman, Curtiss C. Dosier, Joseph J. Mallon, Sean M. Murray, Christy G. Lea, Perry D. Oldham, Russell M. Jeide, Zi Y. Wong, Matthew S. Bellinger, Gregory A. Hermanson, Lauren Keller Katzenellenbogen, Ted M. Cannon, Carol Pitzel Cruz, Josué A. Villalta, Andrew I. Kimmel, Brenden Gingrich, Maria Culic Anderson, Melanie J. Seelig, Mauricio A. Uribe, Curtis R. Huffmire, Christopher L. Ross, Eli A. Loots, Ryan E. Melnick, Yanna S. Bouris, Philip M. Nelson, Marko R. Zoretic, Kerry S. Taylor, Derek C. Dailey, Jarom D. Kesler, Colin B. Heideman, Theodore G. Papagiannis, Nicholas M. Zovko, Adam J. Gilbert, Kimberly J. Miller, Thomas Y. Yee, Agnes Juang, Jason J. Jardine, Jared C. Bunker, Lance D. Smemoe, Joshua J. Stowell, Jonathan E. Bachand, Ali S. Razai, Terry K. Tullis, Derek R. Bayles, Cheryl T. Burgess, Gregory B. Phillips, Brian C. Claassen, Mark Lezama, Sean Ambrosius, Stephen W. Larson, John L. Paik, Michael R. Christensen, Benjamin J. Everton, Jason A. Gersting, Baraa Kahf, Alan G. Laquer, Vlad Teplitskiy, Jeffery L. Hallstrom, Maria V. Stout, William O. Adams, Ian W. Gillies, Andrew W. Lloyd, Mark D. Kachner, Lincoln S. Essig, David R. Trossen, Aaron M. Davis, Jason R. Swartz, Benjamin B. Anger, Jason A. Champion, Daniel V. Gibson, Jeremy J. Carney, Karen Cassidy Selvaggio, Adam B. Powell, Karen J. Lenker, Bryan G. McWhorter, Nathanael R. Luman, Andrea L. Cheek, Damien J. Howard, Jane Q. Dai, Shannon Lam, Peter Law, Mark Metzke, Jacob Peterson, Christie R.W. Matthaei, Vladimir S. Lozan, Paul S. Stellman, Heungsoo Choi, Nicole Rossi Townes, Vikas Bhargava, Jeremy A. Anapol, Scott A. Cromar, Kendall M. Loebbaka, David R. Schmidt, Harnik Shukla, Charlene A. Azema, Morgan R. Coates, Jessica L. Achtsam, Jonathan A. Menkes, Rosaleen H. Chou, Kyu S. Min, Chang Sik Lim, Thomas S.H. Cowan, Devanie A. DuFour, Hans L. Mayer, Jessica C. Sganga, Justin J. Gillett, Alexander J. Martinez, Brian M. Graham, Brian J. Flynn, Mitchell B. Hadley, Robert J. Hilton, Daniel P. Hughes, Andrew E. Morrell, Catherine R. Gourash, Jeremiah S. Helm, David M. Cohen, Jordan Gottdank, Nathan D. Reeves, Brandon G. Smith, Xiaoyan Sabrina Wang, Kregg A. Koch, Deborah S. Shepherd, Mark D. Marsden, Joan Y. Chan, Nicholas A. Belair, Angela K. Dremann, M. Scott Forbes, Elenore Niu, Mark E. Davis, Daniel C. Kiang, Keith M. Lim, Ashley C. Morales, Jordan M. Cox, Albert J. Sueiras, Mark Rubinshtein, Clayton R. Henson, Daniel A. Kamkar, Jacob R. Rosenbaum, Douglas B. Wentzel, Aryeh N. Feinstein, Aaron S. Johnson, Bryan J. Johnson, Chanell Khosrowabadi, Lindsay A. Laddaran, Janet M. Allendorph, Alexander Zeng, Samuel I. Cockriel, Serah R. Friedman, Bita Kianian, Eric R. Malmgren, Justin E. Culbertson, Marissa M. Rosenbaum, Brok S. Humbert, Karl W. Kowallis, Christopher L. Lewis, Ben K. Shiroma, Makoto Tsunozaki, James Yang, Matthew S. Friedrichs, David G. Kim, Silas K. Alexander, Thomas S. Loy, Nima Zargari, Kenneth K. Wang, Brian C. Barnes, Emily J. Asgari, Spencer R. Carter, Xiaoyu Shelley Chen, Alexander P. Slafkosky, Laura E. Liebman, Katherine R. McMorrow, Alexander G. Trimes, Logan P. Young, Julie T. Vo, Matthew I. Burton, Robert C. Arbulu, Steven N. Friedland, Jose A. Martin del Campo, Michelle J. Ziperstein, Cesar A. Estrada, Hyunjin Park, Matthew T. Pham, Timothy A. Trost, Julia N. Hanson, Brianne M. Kingery, Joshua C. Loader, Alistair J. McIntyre, Kenneth P. McNeill, Morgan E. Robertson, Clint A. Saylor, Joseph A.R. Gerber, Holly M. Gordon, Inzer C. Ni, Charles K. Crane, Mingyue Bao, James E. Youngblood, Yusuke Hirai, Erin M. Cardinal, Martin S. Sulsky, and Amit Kulkarni, Charles J. Sirek, and Paige E. Radtke. Jonathan A. Hyman of Knobbe, Martens, Olson & Bear, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      2040 Main Street, 14th Floor
      Irvine, California 92614
      United States
      310-551-4350(phone)
      949-760-9502(fax)
      efiling@knobbe.com
The docket/reference number is RJENK068.009.
Jonathan A. Hyman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Jonathan A. Hyman of Knobbe, Martens, Olson & Bear, LLP
      2040 Main Street, 14th Floor
      Irvine California 92614
      United States
      310-551-4350(phone)
      949-760-9502(fax)
      efiling@knobbe.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:

Jonathan A. Hyman

PRIMARY EMAIL FOR CORRESPONDENCE: efiling@knobbe.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jonathan.hyman@knobbe.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 97298701
Payment Accounting Date: 03/07/2022

Serial Number: 97298701
Internet Transmission Date: Mon Mar 07 13:09:57 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.XX-2022030713095704
5477-97298701-820c4c61fef5685c7dcf96edec
5c31ba53b0cf1b4610a383e2e7cfa7af6e52c8b1
-CC-09554791-20220307130728464121